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Angiogenesis and inﬂammation are persistent features of several pathological conditions. Propolis, a sticky material that
honeybees collect from living plants, has been reported to have multiple biological eﬀects including anti-inﬂammatory and
anti-neoplasic activities. Here, we investigated the eﬀects of water extract of green propolis (WEP) on angiogenesis,inﬂammatory
cell accumulation and endogenous production of cytokines in sponge implants of mice over a 14-day period. Blood vessel
formation as assessed by hemoglobin content and by morphometric analysis of the implants was reduced by WEP (500mgkg−1
orally) compared to the untreated group. The levels of vascular endothelial growth factor (VEGF) increased progressively in the
treated group but decreased after Day 10 in the control group. Accumulation of neutrophils and macrophages was determined by
measuring myeloperoxidase (MPO) and N-acetyl-β-D-glucosaminidase (NAG) activities, respectively. Neutrophil accumulation
was unaﬀected by propolis, but NAG activity was reduced by the treatment at Day 14. The levels TGF-β1 intra-implant
increased progressively in both groups but were higher (40%) at Day 14 in the control implants. The pro-inﬂammatory levels
of TNF-α peaked at Day 7 in the control implants, and at Day 14 in the propolis-treated group. Our results indicate that the
anti-inﬂammatory/anti-angiogeniceﬀects of propolis are associated with cytokine modulation.
1.Introduction
Compelling evidence indicates that angiogenesis and
inﬂammation are key components to the maintenance of
a variety of pathological conditions such as rheumatoid
arthritis, psoriasis, atherosclerosis, neoplasias and Crohn’s
disease. Both processes are mediated by a number of
molecules and cellular events that are essential for activation
of leukocytes and formation of new blood vessels. These
include vascular endothelial growth factor (VEGF), tumor
necrosis factors (TNF) and transforming growth factors
(TGF). Thus, attenuation and/or inhibition of blood vessel
formation and inﬂammatory cell inﬂux to the sites of the
injuries would represent a way to control pathophysiological
processes.
Propolis, a substance produced by honeybees, has a
very complex chemical composition and is dependent
upon the source plant [1]. It has been found to exhibit
anti-bacteria, anti-inﬂammatory, anti-oxidant and anti-
tumor activities [1–6]. These eﬀects of propolis have been
attributed to its main components particularly artepillin C
(a predominant metabolite from green Brazilian propolis)
and caﬀeic acid phenethyl ester (a metabolite found in
Brazilian green propolis and in propolis from temperate
regions) [7–9]. Furthermore, propolis extract has been
shown to suppress corneal neovascularization in rabbit’s
cornea injured by silver nitrate cauterization, through cyclo-
and lipooxygenase pathways [10], and to inhibit angiogen-
esis in the chick embryo chorioallantoic membrane [11].
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and calf pulmonary arterial endothelial cells have shown
that propolis extract inhibited cell proliferation, migration
and capillary tube formation in a dose-dependent manner
[11, 12].
Considering the above-mentioned eﬀects of propolis
and that angiogenesis and inﬂammation co-exist in a
variety of pathological conditions, we hypothesized that
propolis might prevent inﬂammatory angiogenesis. To our
knowledge, there is no study in which the eﬀects of water
extract of green propolis (WEP) on these processes have
been performed simultaneously in a model of inﬂammatory
angiogenesis. The murine sponge model of angiogenesis
oﬀers a unique opportunity to explore key components
of these mutually co-dependent processes allowing the
characterization of both acute and chronic inﬂammatory
responses as well as key components of ﬁbrovascular tissue
(cell inﬂux, blood vessel formation and extracellular matrix
deposition). The eﬀects of various anti-inﬂammatory/anti-
angiogenic compounds have also been determined using this
implantation technique [13, 14].
The present study explores the hypothesis that WEP may
prevent inﬂammatory angiogenesis in the sponge implant
model by determining the eﬀects of systemic administration
of this compound on neovascularization, accumulation of
neutrophils and macrophages together with relevant pro-
angiogenic and pro-inﬂammatory cytokines.
2.Methods
2.1. Preparation of the Aqueous Extract of Green Propolis.
Sample of Brazilian green propolis was collected in
Jaguarac ¸u/Minas Gerais state, Brazil (September 2005 to
September 2006) from Apis mellifera h i v e s .T h es a m p l ew a s
homogenized and frozen at −18◦C and an aliquot (200g)
was crushed and 500ml of distilled water added to make
a suspension. This suspension was maintained for a period
of 30–60min under stirring with a temperature of 70◦C
until full incorporation of propolis. The material was ﬁltered
through paper Whatman #1 to obtain the ﬁrst fraction of the
extractandwaste.Theresiduereceivedthesametreatment to
obtain the second fraction of the extract. The two fractions
of the extract were added together and then lyophilized. For
administration to the animals, the compound was diluted
in water and 200μl of the suspension containing 15mg
(500mgkg−1) of the extract was given to each animal.
2.2. Animals. Female Swiss mice 7-8 weeks (30–35g body
weight) used in these experiments were provided by the
CentralAnimal FacilityattheInstituteofBiologicalSciences,
Federal University of Minas Gerais, Brazil. The animals were
housed individually and provided with chow pellets and
water ad libitum. The light/dark cycle was 12:12h with lights
on at 7:00a.m. and lights oﬀ at 7:00p.m. Eﬀorts were made
to avoid all unnecessary distress to the animals. Housing,
anesthesia and post-operative care adhered with the guide-
lines established in accordance to the Federal University of
Minas Gerais Guidelines for Animal Experimentation. This
experiment was approved by the University’s Committee for
Animal Experimentation (Protocol 161/2005).
2.3. Preparation of Sponge Disks, Implantation and Treatment.
Polyether-polyurethane sponge (Vitafoam Ltd, Manchester,
UK) was used as the implanted material. The implants
were diskshaped, 5mm thick × 8mm diameter and were
soaked overnight in 70% v/v ethanol and sterilized by
boiling in distilled water for 15min before implantation.
Mice were anesthetized by intra-peritoneal injection of
4μlg −1 of a mixture of ketamine (150mgkg−1) and xylazine
(10mgkg−1), their dorsal hair was shaved and their skin was
wiped with 70% ethanol in preparation for implantation.
The sponge disks were aseptically implanted into a subcu-
taneous pouch, which had been made with curved artery
forceps through a 1cm long dorsal mid-line incision. Post-
operatively, the animals were monitored for any signs of
infection at the operative site, discomfort or distress; any
showing such signs were immediately killed. Water extract of
green propolis (WEP) was given orally by gavage to provide
500mgkg−1 day−1. The treatment started on the day of the
implantation and lasted for 14 days. The control group of
mice received saline on the same schedule. The dose of the
compound was chosen based on the pilot experiments and
on data from the literature [15, 16]. The treatment and
sponge implants were well tolerated by the mice during the
experimental period.
2.4.HemoglobinExtraction. Theextentofthevascularization
of the sponge implants was assessed by the amount of
hemoglobin (Hb) detected in the tissue using the Drabkin
method [17]. At Days 4, 7 and 14 post-implantation, groups
ofanimalswereeuthanizedandthespongeimplantscarefully
removed. The sponges were dissected from adherent tissue,
weighed, homogenized (Tekmar TR-10, OH) in 2ml of
Drabkin reagent (Labtest, S˜ ao Paulo, Brazil) and centrifuged
at 4◦C at 12000g for 20min. The supernatants were
ﬁltered through a 0.22μm Millipore ﬁlter. The hemoglobin
concentration of the samples was determined spectropho-
tometrically by measuring absorbance at 540nm using an
ELISA plate reader and was compared against a standard
curve of hemoglobin. The content of hemoglobin in the
implant was expressed as micrograms of Hb per milligram
wet tissue.
2.5. Tissue Extraction and Determination of Myeloperoxidase
and N-Acetyl-β-D-Glucosaminidase Activities. The extent of
neutrophil accumulation in the implants was measured
by assaying myeloperoxidase (MPO) activity as previously
described [18]. After processing the supernatant of the
implants for the hemoglobin determination (see above), a
part of the corresponding pellet was weighed, homogenized
in(2ml)pH4.7buﬀer(0.1MNaCl,0.02MNa3PO4,0.015M
Na2-EDTA) and centrifuged at 4◦C at 12000g for 10min.
The pellets were then re-suspended in 0.05M sodium
phosphate buﬀer (pH 5.4) containing 0.5% hexa-1,6-bis-
decyltrimethylammonium bromide (HTAB). MPO activity
in the supernatant samples was assayed by measuring the
change in absorbance (optical density; OD) at 450nm using
3,3 -5,5 -tetramethylbenzidine (TMB) prepared in dimethyl
sulfoxide (DMSO) in a ﬁnal concentration of 1.6mM and
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The reaction was terminated by the addition of 50μlo f
H2SO4 (4M). Results were expressed as change in OD per
mg of wet tissue.
The inﬁltration of mononuclear cells into the implants
was quantiﬁed by measuring the levels of the lysoso-
mal enzyme N-acetyl-β-d-glucosaminidase (NAG) which is
present in high levels in activated macrophages [18]. Part
of the pellet that remained after the hemoglobin measure-
ment was kept for this assay. These pellets were weighed,
homogenized in NaCl solution (0.9% w/v) containing 0.1%
v/v Triton X-100 (Promega) and centrifuged (3000g; 10min
at 4◦C). Samples of the resulting supernatant (100μl) were
incubated for 10min with 100μl p-nitrophenyl-N-acetyl-
β-d-glucosaminide (Sigma) prepared in the citrate/sodium
phosphate buﬀer (0.1M citric acid, 0.1M Na2HPO4;p H
4.5) to yield a ﬁnal concentration of 2.24mM. The reaction
was stopped by the addition of 100μl of 0.2M glycine
buﬀer(pH 10.6). Hydrolysis of the substrate was determined
by measuring the absorption at 400nm. NAG activity was
expressed as the change in OD per milligram of wet tissue
(implant).
2.6. VEGF, TNF-α and TGF-β1P r o d u c t i o ni nt h eS p o n g e
Implants. For this procedure, the implants were removed
at Days 4, 7 and 14 post-implantation, homogenized in
1.0ml sodium–phosphate buﬀered saline (PBS) pH 7.4
containing 0.05% Tween-20 and centrifuged at 4◦Cf o r
10min at 10000g. The cytokines in the supernatant from
eachimplantweremeasuredin50μlofthesupernatantusing
Immunoassay ELISA Kits (R&D Systems, USA) for murine
VEGF, TNF-α and TGF-β1 following the manufacturer’s
protocol. Brieﬂy, ﬂat-bottom, 96-well microtiter plates were
coated with a speciﬁc murine monoclonal antibody against
the cytokine for 18h at 4◦C and then washed with PBS (pH
7.4) containing 0.05% Tween-20 (wash buﬀer). Non-speciﬁc
binding sites were blocked with 1% bovine serum albumin
(BSA) in PBS (blocking buﬀer). Plates were rinsed with
the wash buﬀer and samples (in 0.1% BSA in PBS-reagent
diluent) were added to the wells, followed by incubation for
18h at 4◦C.
Plates were then washed and appropriate second
horseradish peroxidase-conjugated polyclonal antibody
against the cytokine was added to the wells. Plates were
then washed and the chromogen substrate OPD (o-
phenylendiamine, Sigma) diluted in 0.03M citrate buﬀer
(pH 5.0) containing 0.02% 30 v/v H2O2 was added. The
plates were incubated in the dark for 30min at room
temperature. The reaction was stopped with 2N sulfuric
acid solution (50μl/well). The intensity of the color was
measured at 492nm on a spectrophotometer (Emax-
Molecular Devices). Standards were 0.5-log10 dilutions of
recombinant murine cytokines from 7.5 to 1000pgml−1
(100μl). The results were expressed as picograms of cytokine
per milligram wet tissue.
2.7. Morphometric Analysis and Blood Vessel Quantiﬁcation.
To examine the degree of neovascularization in the implants
ofcontrol(saline)andtreated mice,a totalof18spongedisks
(three for each time point for each group) were processed
for histological assessment. The implants were harvested,
embedded in paraﬃna n d5 - μm-thick sections and stained
w i t hh e m a t o x y l i na n de o s i n( H E )a n de x a m i n e du n d e r
a light microscope. Microscopic images of cross-sections
(5μm) were obtained with aplanapochromatic objective 40x
in light microscopy. The images were digitized through a
JVC TK-1270/JGB microcamera and transferred to an image
analyzer (Kontron Eletronics, Carl Zeiss-KS300 version 2).
A countable microvessel was deﬁned as a structure with a
lumen that contained red blood cells or not. To establish the
minimal representative microscopic ﬁelds per sample, blood
vessels were counted in 50 ﬁelds (400x magniﬁcation, that
is, 40 objective lens and 10 ocular lens; 0.053mm2 per ﬁeld)
from a randomly chosen slide in each group as described
previously [19]. The results were expressed as mean ± SEM
of the total number of vessels/15 ﬁelds.
2.8. Statistical Analysis. Results are presented as mean
± SEM. Statistical comparisons between two groups (N = 8–
10 per group) of mice were carried out using Student’s t-test
for unpaired data. A P<. 05was considered to be statistically
signiﬁcant. Statistical analysis was performed using Graph-
Pad Prism 4.01.
3.Results
3.1.GeneralAssessment ofSystemicAdministration ofPropolis.
Systemic administration of propolis (500mgkg−1 day−1)
during 14 days showed no signs of toxicity such as weight
loss, sedation or alterations in motor activity of the animals.
The surgical procedure,the sponge matrix and the treatment
were well tolerated by all animals. No signs of infection or
rejection were observed in the implant compartment during
the 14-day period of the experiment.
4.Anti-AngiogenicEffects
Daily oral doses of WEP (500mgkg−1) given by gavage to
diﬀerent groups of mice over 14 days reduced neovascu-
larization of the implants, as detected by changes in the
hemoglobin content. A decrease in hemoglobin content was
observed at Days 7 and 14 after the treatment with WEP
(Figure 1(a)). This diﬀerence was further conﬁrmed by the
morphometric analysis of the implants showing that the
number of vessels was markedly lower in the treated group
compared with the control group (Figure 1(b)).
Because VEGF has been considered a marker for angio-
genesis, we have assayed for this molecule in the implants.
Interestingly, the levels of this cytokine increased progres-
sively in the propolis-treated group but decreased in the
control group (Figure 1(c)).
4.1. Leukocyte Accumulation and Cytokine Production. The
inﬂammatory componentsofthesponge-inducedinﬂamma-
tion were determined by estimating the numbers of leuko-
cytes in the implant through assays for enzyme activities.
Neutrophil numbers (as MPO activity) was not aﬀected
by propolis treatment at the time points studied; however,
macrophage accumulation (as NAG activity) decreased4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Eﬀects of WEP on angiogenesis in sponge implants. The hemoglobin content after the systemic treatment (500mgkg−1 day−1)
relative to the control group (a). Morphometric analysis of the vessel number and the levels of VEGF are shown in (b) and (c), respectively.
Values are the means (±SEM) from groups of 8–10 animals. ∗P<. 05 versus the control group.
(∼50%) at Day 14 in the treated group compared with
the control (Figures 2(a) and 2(b)). The levels of pro-
inﬂammatory cytokine (TNF-α)p e a k e da tD a y7i nt h e
control group and at Day 14 in the propolis-treated group
(Figure 3(a)). TGF-β1 levels increased progressively in both
types of implant but propolis treatment was able to reduce
t h ea m o u n to ft h i sc y t o k i n ea tD a y1 4p o s t - i m p l a n t a t i o n
(Figure 3(b)).
5.Discussion
Propolis has been used for various medical purposes since
antiquity, mainly as an anti-inﬂammatory agent and wound
healing promoter [20]. In more recent times, there has
been a considerable interest in the therapeutic properties
of propolis as its anti-infectious, immunomodulatory and
anti-neoplasic actions have been demonstrated [5, 21, 22].
Other actions of propolis assessed in experimental animals
have proved beneﬁcial on acute and chronic inﬂammation
[23–25] and in inhibiting angiogenesis [10–12, 26].
Here, we investigated the eﬀects of WEP on blood
vessel formation, on inﬂammatory enzyme activities and
on cytokines production in a model of sponge implant.
Although, propolis extract has been shown to suppress
corneal angiogenesis in rabbit’s cornea injured by silver
nitrate cauterization [10] and in the chick embryo chorioal-
lantoic membrane [11, 12], our model of angiogenesis
diﬀers importantly from the above-mentioned angiogenesis
systems particularly on its inﬂammatory component. The
corneal model and chick choriallantoic membrane [27, 28]
are minimal inﬂammatory systems compared to the other
assays. In addition, to our knowledge, there is no report
on the eﬀects of WEP on key components of inﬂamma-
tory angiogenesis (blood vessel formation, inﬂammatoryEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: Eﬀects of WEP (500mgkg−1 day−1) on inﬂammatory
enzyme activities. The level of neutrophil accumulation (measured
as myeloperoxidase—MPO activity) is shown in (a). Macrophage
accumulation (measured as N-acetyl-β-d-glucosaminidase-NAG
activity) isshownin (b).Valuesarethemeans(±SEM)fromgroups
of 8–10 animalsin each group. ∗P<. 05 versus the control group.
enzyme activity and cytokine production). Thus, it seemed
reasonable that this compound would modulate the host
inﬂammatory response to synthetic implants. By assessing
WEP in the sponge model, we were able to identify its eﬀects
on critical steps of the formation of the ﬁbrovascular tissue.
Our studies demonstrate a novel inhibitory activity of WEP
on the inﬂammatory and angiogenic components of the
newly formed tissue. The treatment also revealed the eﬀects
of WEP on pro-inﬂammatory and pro-ﬁbrogenic cytokines
within the sponge implants.
The sequential development of angiogenesis, inﬂamma-
tion and cytokine production in the ﬁbrovascular tissue
induced by sponge implantation in mice treated with WEP
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Figure 3: Eﬀects of WEP (500mgkg−1 day−1)o nl e v e l so fT N F - α
(a) and TGF-β1 (b). A distinct pattern in the production of these
cytokines is observed between control and treated implants. Values
shown are the means (±SEM) from groups of 8–10 animals. ∗P<
.05 versus the control group.
diﬀered substantially from the untreated group. Angiogene-
sis assessed bytheHb content(vascular index) ofthesponges
and by morphometric analysis of blood vessel number
increased progressively in both groups but much less in the
propolis-treated group. Interestingly, the levels of the pro-
angiogenic cytokine, VEGF, presented a diﬀerent pattern of
production in both groups. Thus, while in the propolis-
treated group thelevelsincreased progressively, inthe control
group the cytokine production decreased after Day 7 post-
implantation. This lack of correlation between the levels of
VEGF and Hb content in the control group is fully compat-
ible with the notion that in the absence of hypoxic and/or
oxidative stress, the levels of VEGF would drop [29, 30]. It
is possible that the blood supply (Hb) content and vessel
number in the implant compartment from Day 7 onwards6 Evidence-Based Complementary and Alternative Medicine
Sponge matrix
Inﬂamed environment
Inﬂammatory cells recruitment/activation
↓ Macrophages
WEP ↓ TGF-β
↑ TNF-α
↓ Inﬂammatory enzyme ↓ Cytokine production
↓ Angiogenesis
↑ VEGF
Figure 4: Diagram representing the sequence of major cellular and
molecular events modulated by WEP in sponge-induced inﬂam-
matory angiogenesis. The eﬀect of WEP decreasing macrophage
recruitment/activation leads to low production of N-acety-β-D-
glucosaminidase enzyme. WEP modulates cytokine production in
the implants by increasing the levels of VEGF and TNF-α and
decreasing the levels of TGF-β1. These cytokines play an important
role in regulating extracellular matrix deposition.
in the control group would be enough to comply with the
metabolic demand at the site which in turn would result
in inhibitory signal to VEGF production. Conversely, in the
propolis-treated group decreased angiogenesis stimulated
the production of VEGF to compensate for deﬁcient blood
supply in the implant compartment.
The inﬂammatory components of the implants were
assessed by inﬂammatory enzymes and cytokines. In the
propolis-treated group,MPO activity (representing activated
neutrophils) was not aﬀected by the treatment, showing a
lack of WEP eﬀect on this inﬂammatory cell population.
The compound, however, was able to inhibit markedly NAG
activity (representing activated macrophages/monocytes) at
Day14post-implantationsuggestingadegreeofselectivityof
propolis for this cell population. Our results are in line with
those by Orsolic and Basic [31] that showed a decrease in
macrophage recruitment in the peritoneal cavity in animals
treated with aqueous extract of propolis.
The pattern of TNF-α and TGF-β1 production (two
relevant inﬂammatory and ﬁbrogenic cytokines) was also
inﬂuenced by WEP. The levels of TNF-α peaked in the
control group at Day 7 and in the propolis-treated group
at Day 14. Diﬀerently, the kinetics of TGF-β1 production in
the implants had parallel courses in both types of implants
but the amount of this cytokine was ∼1.5-fold in the control
group at Day 14 relative to the treated group. These results
clearly indicate that the beneﬁcial eﬀects of propolis in
our system have occurred through modulation of these
cytokines that perform well-established roles in regulating
extracellular matrix deposition in wound healing [32]. The
fact that CAPE and other caﬀeoylquinic acids and artepillin
C have been shown to exert most of the biological activities
studied [3, 14, 23–25] and that these components were
identiﬁed in our aqueous extract of the Brazilian green
propolis [33], it seems reasonable to attribute, at least in
part, the anti-inﬂammatory and anti-angiogenic eﬀects of
propolis to these components. We cannot rule out, however,
the possibility that other constituents found in the green
propolis are involved in the inhibition of key components of
inﬂammatory angiogenesis observed in our study.
To our knowledge, this is the ﬁrst report that assessed the
eﬀects of WEP on multiple parameters of the main compo-
nents of inﬂammatory angiogenesis. Moreover, a regulatory
function of WEP on pro-inﬂammatory and pro-ﬁbrogenic
cytokines production has been revealed (Figure 4). Alto-
gether, our results conﬁrm and extend previous ﬁndings of
the therapeutic eﬀects of propolis which are likely to be
associated with regulation of cytokines that are secreted by
i n ﬂ a m m a t o r yc e l l sa tt h es i t eo ft i s s u ei n j u r y .
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